CentralCharts: Supercharge your portfolio with groundbreaking tools.

ABIVAX Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 08-May-2024 / 08:30 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 PARIS, France, May 8,...

EQS-News: Wolftank-Adisa Holding AG / Key word(s): Incoming Orders/Contract Wolftank Group secures two new major orders in Italy with a total value of EUR 6.7 million 08.05.2024 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement. Wolftank Group secures two new major orders in Italy with a total value of EUR 6.7 million Wolftank Group (Wolftank-Adisa Holding AG, ISIN: AT0000A25NJ6), a specialist in environmental and energy technologies with a focus on emission...

Securitas AB Interim Report Q1 2024 January-March PR Newswire STOCKHOLM, May 8, 2024 STOCKHOLM , May 8, 2024 /PRNewswire/ -- January–March 2024 Total sales MSEK 39 260 (37 751) Organic sales growth 7 percent (12) Real sales growth within technology and solutions 7 percent (77) Operating income before amortization MSEK 2 357 (2 180) Operating margin 6.0 percent (5.8) Earnings per share SEK 1.84 (1.66) Earnings per share before IAC, SEK 2.12 (2.03) Net debt/EBITDA ratio 2.9 (3.3*) Cash flow from...

Securitas AB Interim Report Q1 2024 January-March PR Newswire STOCKHOLM, May 8, 2024 STOCKHOLM , May 8, 2024 /PRNewswire/ -- January–March 2024 Total sales MSEK 39 260 (37 751) Organic sales growth 7 percent (12) Real sales growth within technology and solutions 7 percent (77) Operating income before amortization MSEK 2 357 (2 180) Operating margin 6.0 percent (5.8) Earnings per share SEK 1.84 (1.66) Earnings per share before IAC, SEK 2.12 (2.03) Net debt/EBITDA ratio 2.9 (3.3*) Cash flow from...

Orexo Q1 2024 Interim Report PR Newswire UPPSALA, Sweden, May 8, 2024 UPPSALA, Sweden , May 8, 2024 /PRNewswire/ -- Starting 2024 with a positive EBITDA Q1 2024 highlights Total net revenues of SEK 139.3 m (158.8) EBITDA of SEK 15.9 m (-41.1) Net earnings of SEK -8.9 m (-63.9) US Commercial segment net revenues of SEK 129.3 m (140.3), in local currency USD 12.4 m (13.5) Cash flow from operating activities of SEK -18.9 m (-61.6), cash and invested funds of SEK 198.0 m (278.9) Earnings per share...

- Order intake grew YoY in all segments driven by successes in GTCC, Nuclear Power, and Defense & Space businesses. - Revenue was up YoY in all segments with largest contributions from Metals Machinery, Logistics Systems, and Defense & Space. - Business profit increased in all segments as factors including higher revenue, cost passthroughs, and the weak yen offset one-time charges, investments, and cost inflation. - Free cash flow significantly increased YoY from higher profits, which...

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree abrdn European Logistics Income plc (c) Name of the party to the offer with which exempt principal...

STOCKHOLM, SWEDEN / ACCESSWIRE / May 8, 2024 / Bambuser AB (STO:BUSER)(FRA:5JL) Bambuser reports a Q1 2024 ARR of SEK 98.9 million, representing a quarter over quarter decline of 8% at constant exchange rates ("CER"). The Adjusted EBITDA was SEK -24.8 million, in line with implemented cost enhancements. The free cash flow for the quarter ended at SEK -24.7 million, a year over year improvement of SEK 6 million. The cash balance closed at SEK 247.3 million, which is sufficient to take Bambuser to...